Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Insulin and Its Effect on Postprandial Glucose Metabolism in Comparison to Subcutaneous Insulin

NCT00850161 is registered in ClinicalTrials.gov with CPEX Pharmaceuticals Inc. as lead sponsor.

NCT NCT00850161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00850161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Insulin and Its Effect on Postprandial Glucose Metabolism in Comparison to Subcutaneous Insulin
Lead sponsor
CPEX Pharmaceuticals Inc.
Phase
Phase 2
Overall status
Withdrawn
Start date
July 31, 2009
Completion date
September 30, 2010
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes mellitus